{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:45:19Z","timestamp":1765701919919,"version":"3.48.0"},"reference-count":43,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,1,28]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Sentinel lymph node biopsy (SLNB) is a diagnostic procedure developed in the 1990s. It is currently used to stage patients with primary cutaneous melanoma, provide prognostic information and guide management. The Australian Clinical Practice Guidelines state that SLNB should be considered for patients with cutaneous melanoma &gt;1\u2009mm in thickness (or &gt;0.8\u2009mm with high-risk pathology features). Until recently, sentinel lymph node (SLN) status was used to identify patients who might benefit from a completion lymph node dissection, a procedure that is no longer routinely recommended. SLN status is now also being used to identify patients who might benefit from systemic adjuvant therapies such as anti-programmed cell death 1 (PD1) checkpoint inhibitor immunotherapy or BRAF-directed molecular targeted therapy, treatments that have significantly improved relapse-free survival for patients with resected stage III melanoma and improved overall survival of patients with unresectable stage III and stage IV melanoma. Australian and international data indicate that approximately half of eligible patients receive an SLNB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This mixed-methods study seeks to understand the structural, contextual and cultural factors affecting implementation of the SLNB guidelines. Data collection will include: (1) cross-sectional questionnaires and semistructured interviews with general practitioners and dermatologists; (2) semistructured interviews with other healthcare professionals involved in the diagnosis and early definitive care of melanoma patients and key stakeholders including researchers, representatives of professional colleges, training organisations and consumer melanoma groups; and (3) documentary analysis of documents from government, health services and non-government organisations. Descriptive analyses and multivariable regression models will be used to examine factors related to SLNB practices and attitudes. Qualitative data will be analysed using thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval has been granted by the University of Sydney. Results will be disseminated through publications and presentations to clinicians, patients, policymakers and researchers and will inform the development of strategies for implementing SLNB guidelines in Australia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-032636","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T04:15:24Z","timestamp":1582863324000},"page":"e032636","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4428-2826","authenticated-orcid":false,"given":"Frances","family":"Rapport","sequence":"first","affiliation":[{"name":"Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9194-4888","authenticated-orcid":false,"given":"Andrea L","family":"Smith","sequence":"additional","affiliation":[{"name":"Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia"},{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E","family":"Cust","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham J","family":"Mann","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"},{"name":"The John Curtin School of Medical Research, Australian National Univeristy, Canberra, Australian Capital Territory, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline G","family":"Watts","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Gyorki","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Henderson","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M","family":"Hong","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"},{"name":"Sydney School of Medicine, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W","family":"Kelly","sequence":"additional","affiliation":[{"name":"Victorian Melanoma Service, The Alfred Hosptial, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina V","family":"Long","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"},{"name":"Sydney School of Medicine, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria J","family":"Mar","sequence":"additional","affiliation":[{"name":"Victorian Melanoma Service, The Alfred Hosptial, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael L","family":"Morton","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"},{"name":"NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn PM","family":"Saw","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"},{"name":"Sydney School of Medicine, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A","family":"Scolyer","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"},{"name":"Sydney School of Medicine, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Spillane","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"},{"name":"Sydney School of Medicine, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Thompson","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Sydney, New South Wales, Australia"},{"name":"Sydney School of Medicine, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0296-4957","authenticated-orcid":false,"given":"Jeffrey","family":"Braithwaite","sequence":"additional","affiliation":[{"name":"Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"unstructured":"Australian Institute of Health and Welfare (AIHW) . 2018 cancer data in Australia; Australian cancer incidence and mortality (ACIM) books: melanoma of the skin. Canberra: AIHW, 2019. https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia\/","key":"2025121400414994000_10.2.e032636.1"},{"key":"2025121400414994000_10.2.e032636.2","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"unstructured":"Mahul AB , Edge S , Greene F , et al . AJCC cancer staging manual. 8th ed. Chicago: Springer International Publishing, 2017 ..","key":"2025121400414994000_10.2.e032636.3"},{"key":"2025121400414994000_10.2.e032636.4","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.5","DOI":"10.1001\/archsurg.1992.01420040034005"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.6","DOI":"10.1038\/sj.bjc.6605849"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.7","DOI":"10.1245\/s10434-008-0164-z"},{"key":"2025121400414994000_10.2.e032636.8","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025121400414994000_10.2.e032636.9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"key":"2025121400414994000_10.2.e032636.10","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMe1711199","article-title":"Adjuvant melanoma therapy - head-spinning progress","volume":"377","author":"Schuchter","year":"2017","journal-title":"N Engl J Med"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.11","DOI":"10.1056\/NEJMoa1708539"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.12","DOI":"10.1056\/NEJMoa1709030"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.13","DOI":"10.1056\/NEJMoa1802357"},{"key":"2025121400414994000_10.2.e032636.14","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"unstructured":"Gyorki D , Barbour A , Mar V , et al . Cancer Council Australia melanoma guidelines Working Party. when is a sentinel node biopsy indicated? 2019. Available: http:\/\/wiki.cancer.org.au\/australia\/Clinical_question:When_is_a_sentinel_node_biopsy_indicated%3F [Accessed 19 Dec 2019].","key":"2025121400414994000_10.2.e032636.15"},{"key":"2025121400414994000_10.2.e032636.16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jso.24013","article-title":"Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia","volume":"112","author":"Smithers","year":"2015","journal-title":"J Surg Oncol"},{"key":"2025121400414994000_10.2.e032636.17","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1245\/s10434-017-5890-7","article-title":"Poor adherence to national clinical management guidelines: a population-based, cross-sectional study of the surgical management of melanoma in New South Wales, Australia","volume":"24","author":"Varey","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2025121400414994000_10.2.e032636.18","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-10-54","article-title":"Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patients","volume":"10","author":"Silva","year":"2012","journal-title":"World J Surg Oncol"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.19","DOI":"10.1001\/archderm.144.5.629"},{"key":"2025121400414994000_10.2.e032636.20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jss.2013.04.091","article-title":"Assessing rural-urban disparities in the use of sentinel lymph node biopsy for melanoma","volume":"184","author":"Shah","year":"2013","journal-title":"J Surg Res"},{"key":"2025121400414994000_10.2.e032636.21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.canep.2012.06.006","article-title":"Regional inequalities in cancer care persist in Italy and can influence survival","volume":"36","author":"Sant","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"2025121400414994000_10.2.e032636.22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jso.24936","article-title":"Melanoma patterns of care in Ontario: a call for a strategic alignment of multidisciplinary care","volume":"117","author":"Look Hong","year":"2018","journal-title":"J Surg Oncol"},{"key":"2025121400414994000_10.2.e032636.23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jso.23981","article-title":"A population-based assessment of melanoma: does treatment in a regional cancer center make a difference?","volume":"112","author":"Rivard","year":"2015","journal-title":"J Surg Oncol"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.24","DOI":"10.1016\/j.amjsurg.2005.01.039"},{"key":"2025121400414994000_10.2.e032636.25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-019-07204-2","article-title":"Trends in sentinel lymph node biopsy enactment for cutaneous melanoma","volume":"26","author":"El Sharouni","year":"2019","journal-title":"Ann Surg Oncol"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.26","DOI":"10.1177\/1363459303007003004"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.27","DOI":"10.1016\/S0140-6736(09)61440-9"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.28","DOI":"10.1111\/j.0887-378X.2004.00325.x"},{"unstructured":"Ferlie E , Gabbay J , Fitzgerald L , et al . Evidence-based medicine and organisational change: an overview of some recent qualitative research. In: Ashburner L , ed. Organisational behaviour and organisational studies in health care: reflections on the future. Basingstoke: Palgrave Macmillan, 2001: 18\u201342.","key":"2025121400414994000_10.2.e032636.29"},{"key":"2025121400414994000_10.2.e032636.30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1748-5908-8-35","article-title":"A checklist for identifying determinants of practice: A systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice","volume":"8","author":"Flottorp","year":"2013","journal-title":"Implementation Science"},{"key":"2025121400414994000_10.2.e032636.31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1748-5908-6-103","article-title":"Tailored implementation for chronic diseases (TICD): a project protocol","volume":"6","author":"Wensing","year":"2011","journal-title":"Implement Sci"},{"unstructured":"Rapport F , Hogden A , Faris M , et al . Qualitative research in healthcare: modern methods, clear translation. A white paper. Sydney: Macquarie University, 2018.","key":"2025121400414994000_10.2.e032636.32"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.33","DOI":"10.1093\/intqhc\/mzm042"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.34","DOI":"10.1016\/j.ijsu.2014.07.013"},{"unstructured":"Miles M , Huberman M . Qualitative data analysis: an expanded sourcebook. Thousand Oaks: SAGE Publishing, 1994.","key":"2025121400414994000_10.2.e032636.35"},{"unstructured":"Charmaz K . Constructing grounded theory: a practical guide through qualitative analysis. Thousand Oaks: SAGE Publications, 2006.","key":"2025121400414994000_10.2.e032636.36"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.37","DOI":"10.1016\/j.jbi.2008.08.010"},{"unstructured":"Australian Bureau of Statistics (ABS) . Socio-economic indexes for areas (SEIFA), 2018. Available: http:\/\/www.abs.gov.au\/websitedbs\/censushome.nsf\/home\/seifa","key":"2025121400414994000_10.2.e032636.38"},{"unstructured":"Australian Bureau of Statistics (ABS) . The Australian statistical geography standard (ASGS) remoteness structure, 2018. Available: http:\/\/www.abs.gov.au\/websitedbs\/d3310114.nsf\/home\/remoteness+structure13","key":"2025121400414994000_10.2.e032636.39"},{"key":"2025121400414994000_10.2.e032636.40","first-page":"1","article-title":"Reflecting on thematic analysis","volume":"11","author":"Clarke","year":"2019","journal-title":"Qual Res Sport Exercise Health"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.41","DOI":"10.1191\/1478088706qp063oa"},{"doi-asserted-by":"publisher","key":"2025121400414994000_10.2.e032636.42","DOI":"10.3316\/QRJ0902027"},{"unstructured":"The National Health and Medical Research Council, the Australian Research Council and Universities Australia . National statement on ethical conduct in human research 2007 (updated 2018). Canberra: Commonwealth of Australia, 2018.","key":"2025121400414994000_10.2.e032636.43"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-032636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:42:04Z","timestamp":1765701724000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-032636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,27]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/bmjopen-2019-032636"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-032636","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}